Zobrazeno 1 - 10
of 2 539
pro vyhledávání: '"Buprenorphine/naloxone"'
Autor:
Kim MJ; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Walker H; Baylor College of Medicine, Houston, Texas, USA., Clark M; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Reddy A; Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of palliative medicine [J Palliat Med] 2024 Oct; Vol. 27 (10), pp. 1421-1424. Date of Electronic Publication: 2024 Apr 30.
Autor:
Türker ZG; Department of Psychiatry, Akdeniz University Faculty of Medicine, Antalya, Turkey., Erdoğan A; Department of Psychiatry, Akdeniz University Faculty of Medicine, Antalya, Turkey., Cinemre B; Department of Psychiatry, Akdeniz University Faculty of Medicine, Antalya, Turkey., Metin Ö; Department of Psychiatry, Akdeniz University Faculty of Medicine, Antalya, Turkey., Kulaksızoğlu B; Department of Psychiatry, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Publikováno v:
Human psychopharmacology [Hum Psychopharmacol] 2024 Nov; Vol. 39 (6), pp. e2908. Date of Electronic Publication: 2024 Jul 14.
Autor:
Young GJ; Center for Health Policy and Healthcare Research, Northeastern University, Boston, MA, USA.; Bouve College of Health Sciences, Northeastern University, Boston, MA, USA.; D'Amore-McKim School of Business, Northeastern University, Boston, MA, USA., Young LD; Prescription Monitoring Program, Massachusetts Department of Public Health, Boston, MA, USA., Noor-E-Alam M; Center for Health Policy and Healthcare Research, Northeastern University, Boston, MA, USA. mnalam@neu.edu.; Department of Mechanical and Industrial Engineering, College of Engineering, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, USA. mnalam@neu.edu.
Publikováno v:
Addiction science & clinical practice [Addict Sci Clin Pract] 2024 Nov 21; Vol. 19 (1), pp. 85. Date of Electronic Publication: 2024 Nov 21.
Autor:
Langlois J; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Fairbairn N; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Jutras-Aswad D; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Le Foll B; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada.; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Translational Addiction Research Laboratory, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada., Lim R; Department of Family Medicine and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Socías ME; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
The American journal on addictions [Am J Addict] 2024 Nov; Vol. 33 (6), pp. 664-674. Date of Electronic Publication: 2024 Jun 15.
Buprenorphine/naloxone micro-induction in a tertiary care hospital: a retrospective cohort analysis.
Autor:
Nunn R; St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Sylvestre A; St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Sequeira K; St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada., Tanzini RM; St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
Publikováno v:
Journal of addictive diseases [J Addict Dis] 2024 Oct-Dec; Vol. 42 (4), pp. 345-351. Date of Electronic Publication: 2023 Jul 02.
Autor:
Nateghi Haredasht F; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.; Division of Hospital Medicine, Stanford University, Stanford, California, USA.; Clinical Excellence Research Center, Stanford University, Stanford, California, USA., Fouladvand S; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.; Division of Hospital Medicine, Stanford University, Stanford, California, USA.; Clinical Excellence Research Center, Stanford University, Stanford, California, USA., Tate S; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA., Chan MM; Holmusk Technologies, Inc., Singapore, Singapore.; Holmusk Technologies, Inc., New York, New York, USA., Yeow JJL; Holmusk Technologies, Inc., Singapore, Singapore.; Holmusk Technologies, Inc., New York, New York, USA., Griffiths K; Holmusk Technologies, Inc., Singapore, Singapore.; Holmusk Technologies, Inc., New York, New York, USA., Lopez I; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.; Division of Hospital Medicine, Stanford University, Stanford, California, USA.; Clinical Excellence Research Center, Stanford University, Stanford, California, USA., Bertz JW; Center for the Clinical Trials Network, National Institute on Drug Abuse, North Bethesda, Maryland, USA., Miner AS; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA., Hernandez-Boussard T; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.; Division of Hospital Medicine, Stanford University, Stanford, California, USA.; Clinical Excellence Research Center, Stanford University, Stanford, California, USA., Chen CA; Division of Primary Care and Population Health, Department of Medicine Stanford University School of Medicine, Stanford, California, USA., Deng H; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA., Humphreys K; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA., Lembke A; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA., Vance LA; Holmusk Technologies, Inc., Singapore, Singapore.; Holmusk Technologies, Inc., New York, New York, USA., Chen JH; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California, USA.; Division of Hospital Medicine, Stanford University, Stanford, California, USA.; Clinical Excellence Research Center, Stanford University, Stanford, California, USA.
Publikováno v:
Addiction (Abingdon, England) [Addiction] 2024 Oct; Vol. 119 (10), pp. 1792-1802. Date of Electronic Publication: 2024 Jun 24.
Autor:
Straub L; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Bateman BT; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California., Hernández-Díaz S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Zhu Y; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Suarez EA; Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey.; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey., Vine SM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Jones HE; UNC Horizons and Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill., Connery HS; Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Davis JM; Department of Pediatrics, Tufts Medical Center and Tufts Clinical and Translational Science Institute, Boston, Massachusetts., Gray KJ; Department of Obstetrics and Gynecology, University of Washington, Seattle., Lester B; Center for the Study of Children at Risk, Departments of Psychiatry and Pediatrics, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Women & Infants Hospital, Providence, Rhode Island., Terplan M; Friends Research Institute, Baltimore, Maryland., Zakoul H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mogun H; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA [JAMA] 2024 Sep 10; Vol. 332 (10), pp. 805-816.
Autor:
Jansson LM; Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, MD 21224, USA. Electronic address: ljansson@jhmi.edu., McConnell K; Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, MD 21224, USA., Velez ML; Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, MD 21224, USA., Spencer N; Johns Hopkins Bayview Medical Center, Department of Nursing, Baltimore, MD 21224, USA., Milio L; Johns Hopkins University School of Medicine, Department of Gynecology and Obstetrics, Baltimore, MD 21224, USA., Leoutsakos J; Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, MD 21224, USA., DiPietro JA; Johns Hopkins Bloomberg School of Public Health, Department of Population, Family and Reproductive Health, Baltimore, MD 21224, USA.
Publikováno v:
Neurotoxicology and teratology [Neurotoxicol Teratol] 2024 Jul-Aug; Vol. 104, pp. 107368. Date of Electronic Publication: 2024 Jun 19.
Autor:
Bastien G; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Abboud A; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., McAnulty C; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Elkrief L; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada., Ledjiar O; Unité de recherche clinique appliquée, Centre hospitalier universitaire Ste-Justine, Montréal, Québec, Canada., Socias ME; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, University of British Columbia, Vancouver, British Columbia, Canada., Le Foll B; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Bahji A; Department of Medicine and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Brissette S; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Marsan S; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada., Jutras-Aswad D; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Publikováno v:
Journal of dual diagnosis [J Dual Diagn] 2024 Jul-Sep; Vol. 20 (3), pp. 189-200. Date of Electronic Publication: 2024 Apr 05.
Autor:
Afshar M; From the University of Wisconsin School of Medicine and Public Health, Madison, WI (MA, EJGL, ABS, EMS-A, MMC); New York University Grossman School of Medicine, New York, NY (JR); Washington University School of Medicine, Saint Louis, MO (PS); and Vanderbilt University Medical Center, Nashville, TN (MWS)., Graham Linck EJ, Spicer AB, Rotrosen J, Salisbury-Afshar EM, Sinha P, Semler MW, Churpek MM
Publikováno v:
Journal of addiction medicine [J Addict Med] 2024 Sep-Oct 01; Vol. 18 (5), pp. 511-519. Date of Electronic Publication: 2024 May 22.